Morgan Stanley’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.8K | Sell |
|
|||||
|
2025
Q1 | $223K | Sell |
|
|||||
|
2024
Q4 | $4.17M | Buy |
|
|||||
|
2024
Q3 | $584K | Sell |
|
|||||
|
2024
Q2 | $4.06M | Buy |
|
|||||
|
2024
Q1 | $3.83M | Sell |
|
|||||
|
2023
Q4 | $12.3M | Buy |
|
|||||
|
2023
Q3 | $1.6M | Buy |
|
|||||
|
2023
Q2 | $1.82M | Sell |
|
|||||
|
2023
Q1 | $1.42M | Sell |
|
|||||
|
2022
Q4 | $5.48M | Buy |
|
|||||
|
2022
Q3 | $3.8M | Sell |
|
|||||
|
2022
Q2 | $3.59M | Buy |
|
|||||
|
2022
Q1 | $6.5M | Buy |
|
|||||
|
2021
Q4 | $5.47M | Buy |
|
|||||
|
2021
Q3 | $6.01M | Sell |
|
|||||
|
2021
Q2 | $5.52M | Buy |
|
|||||
|
2021
Q1 | $336K | Sell |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|
|||||
|
2020
Q3 | $72K | Buy |
|